The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Valsartan Rowa 80 mg film-coated tablets

80 milligram(s) Film-coated tablet

Rowa Pharmaceuticals LimitedPA0074/083/002

Main Information

Trade NameValsartan Rowa 80 mg film-coated tablets
Active SubstancesValsartan
Strength80 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderRowa Pharmaceuticals Limited
Licence NumberPA0074/083/002

Group Information

ATC CodeC09CA Angiotensin II antagonists, plain
C09CA03 valsartan

Status

Authorised/WithdrawnAuthorised
Licence Issued21/04/2011
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0038-005-003
Interchangeable List DocumentPDF of Interchangeable List
« Back